Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaime O Claudio

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Blood|August 30, 2002
A molecular compendium of genes expressed in multiple myelomaJaime O Claudio, Esther Masih-Khan, Hongchang Tang, et al.
Cancer Research|May 6, 2004
Soluble interleukin-13Ralpha2 decoy receptor inhibits Hodgkin's lymphoma growth in vitro and in vivoYoung Trieu, Xiao-Yan Wen, Brian F Skinnider, et al.
Haematologica|January 4, 2020
Measurable residual disease monitoring provides insufficient lead-time to prevent morphologic relapse in the majority of patients with core-binding factor acute myeloid leukemiaRobert Puckrin, Eshetu G Atenafu, Jaime O Claudio, et al.
Leukemia|March 29, 2022
Clinical and molecular correlates of JAK-inhibitor therapy failure in myelofibrosis: long-term data from a molecularly annotated cohortJames T England, Caroline J McNamara, James A Kennedy, et al.
Arthritis Research & Therapy|September 12, 2008
Reduced proportions of natural killer T cells are present in the relatives of lupus patients and are associated with autoimmunityJoan Wither, Yong-chun Cai, Sooyeol Lim, et al.
Blood|January 2, 2026
A Stem and Progenitor Cell-Derived Gene Expression Signature is Prognostic for Survival in MyelofibrosisJessie J F Medeiros, Andy G X Zeng, Suraj Bansal, et al.
Blood Advances|October 18, 2018
The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomesCaroline J McNamara, Tony Panzarella, James A Kennedy, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Blood|August 30, 2002
A molecular compendium of genes expressed in multiple myelomaJaime O Claudio, Esther Masih-Khan, Hongchang Tang, et al.
Cancer Research|May 6, 2004
Soluble interleukin-13Ralpha2 decoy receptor inhibits Hodgkin's lymphoma growth in vitro and in vivoYoung Trieu, Xiao-Yan Wen, Brian F Skinnider, et al.
Haematologica|January 4, 2020
Measurable residual disease monitoring provides insufficient lead-time to prevent morphologic relapse in the majority of patients with core-binding factor acute myeloid leukemiaRobert Puckrin, Eshetu G Atenafu, Jaime O Claudio, et al.
Leukemia|March 29, 2022
Clinical and molecular correlates of JAK-inhibitor therapy failure in myelofibrosis: long-term data from a molecularly annotated cohortJames T England, Caroline J McNamara, James A Kennedy, et al.
Arthritis Research & Therapy|September 12, 2008
Reduced proportions of natural killer T cells are present in the relatives of lupus patients and are associated with autoimmunityJoan Wither, Yong-chun Cai, Sooyeol Lim, et al.
Blood|January 2, 2026
A Stem and Progenitor Cell-Derived Gene Expression Signature is Prognostic for Survival in MyelofibrosisJessie J F Medeiros, Andy G X Zeng, Suraj Bansal, et al.
Blood Advances|October 18, 2018
The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomesCaroline J McNamara, Tony Panzarella, James A Kennedy, et al.
Pageof 2